Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains-Reference-Cited by-同舟云学术

Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains

Published:2017-12 Issue:1 Volume:9 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Lemoine Laetitia,Gillberg Per-Göran,Svedberg Marie,Stepanov Vladimir,Jia Zhisheng,Huang Jinghai,Nag Sangram,Tian He,Ghetti Bernardino,Okamura Nobuyuki,Higuchi Makoto,Halldin Christer,Nordberg Agneta

Funder

Stiftelsen för Strategisk Forskning

swedish research council

stockholm county council karolinska institutet regional agreement on medical training and clinical research (ALF grant)

Swedish brain foundation

alzheimer foundation in sweden

EU FP7 large-scale integrating project INMind

the foundation for Old Servants

gun och bertil stohne's foundation

gunvor och josef anérs stiftelsen

Loo och Hans Ostermans Stiftelse för Medicinsk Forskning (SE)

Tore Nilsons Stiftelse för Medicinsk Forskning (SE)

ki foundation for geriatric diseases

gamla tjänarinnor stiftelsen

demensfonden stiftelsen

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-017-0325-z.pdf

Reference33 articles.

1. Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, Read S, Satyamurthy N, Petric A, Huang SC, et al. Localization of neurofibrillary tangles and β-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry. 2002;10(1):24–35.

2. Thompson PW, Ye L, Morgenstern JL, Sue L, Beach TG, Judd DJ, Shipley NJ, Libri V, Lockhart A. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologies. J Neurochem. 2009;109(2):623–30. doi: 10.1111/j.1471-4159.2009.05996.x .

3. Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A, Cole GM, Small GW, Huang SC, Barrio JR. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for β-amyloid plaques in Alzheimer’s disease. J Neurosci. 2001;21(24):RC189. https://www.ncbi.nlm.nih.gov/pubmed/11734604 .

4. Maruyama M, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J, Zhang MR, Trojanowski JQ, Lee VM, Ono M, et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron. 2013;79(6):1094–108. doi: 10.1016/j.neuron.2013.07.037 .

5. Velasco A, Fraser G, Delobel P, Ghetti B, Lavenir I, Goedert M. Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans, trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene]. FEBS Lett. 2008;582(6):901–6. doi: 10.1016/j.febslet.2008.02.025 .

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radioiodinated Tau Imaging Agent III Molecular Modeling, Synthesis, and Evaluation of a New Tau Imaging Agent, [125I]ISAS in Post-Mortem Human Alzheimer’s Disease Brain;Molecules;2024-07-13

2. Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer’s disease;Neural Regeneration Research;2024-07-10

3. Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, tau and alpha-synuclein;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-02

4. Partial volume correction in longitudinal tau PET studies: is it really needed?;NeuroImage;2024-04

5. A closer look at amyloid ligands, and what they tell us about protein aggregates;Chemical Society Reviews;2024